Case Study: Epimelis Capital achieves scalable, automated front-to-back trading and accounting with Enfusion

Why Epimelis chose Enfusion as their partner, with local expertise and a platform that provides support for trading Chinese instruments and event-driven strategies

Epimelis Capital, a Hong Kong-based, China-focused hedge fund managing under $100M and launched in early 2023, rapidly grew to 300 equity positions and needed a robust system to manage a high-volume, long/short event-driven strategy. Founder Fei Sun chose Enfusion and implemented Enfusion’s PMS, OEMS, and general ledger to replace spreadsheet-based workflows and handle China-specific market complexities like China Connect and QFII.

Enfusion delivered a straight-through front-to-back platform that consolidated portfolio management, trading, compliance and accounting, enabling Epimelis to average 50 trades a day, turn the portfolio 6–10 times a year, and move automation from ~90% to essentially 100%. The solution improved T+1 reconciliation, automated equity swap and FX workflows (including drop copy and FIX tag automation), reduced tasks that took an hour in Excel to minutes, and gave rapid access to P&L and exposure data—significantly boosting operational efficiency and accuracy for Epimelis.

Epimelis Capital

Fei Sun

Founder and CEO